A step forward in the treatment of chronic urticaria

(IMIM (Hospital del Mar Medical Research Institute)) An international study involving dermatologists from the Hospital del Mar and IMIM has concluded that a drug normally used to treat severe bronchial asthma caused by allergies (Omalizumab) rapidly eliminates the symptoms of spontaneous chronic urticaria, a development that it is expected will significantly improve the quality of life of chronic urticaria sufferers.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news